STAT3 and hepatocellular carcinoma: IL-6, in turn, is a key STAT3 activator, and the activation of STAT3 has been shown to play a prominent role in cell survival and proliferation, tissue invasion, angiogenesis, and promotion of HCC development [316,321,322].